1Akbar DH, Kawther AH. Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know. Med Sci Monit, 2006,12 : RA23-26.
2Salgado Junior W, Santos JS, Sankarankutty AK, et al. Nonalcoholic fatty liver disease and obesity. Acta Cir. Bras, 2006,21:72- 78.
3Leclercq IA, Da Silva Morals A, Schroyen B, et al. Insulin resistance in hepatocytes and sinusoidal liver cells:Mechanisms and consequences. J Hepatol, 2007, 47:142-156.
4Shimano H. Sterol regulatory element-binding proteins (SREBPs) : transcriptional regulators of lipid synthetic genes. Prog Lipid Res,2001,40: 439-452.
5Cagen LM, Deng X, Wilcox HG, et al. Insulin activates the rat sterol regulatory element binding protein Ic(SREBP-Ic) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NFY cis-acting elements. Biochem J, 2005, 385: 207-216.
6Fleischmann M, Iynedjian PB. Regulation of sterol regulatory-element binding protein 1 gene expression in liver: role of insulin and protein kinase B/cAkt. Biochem J, 2000, 349: 13-17.
7Ahmed MH, Byrne CD. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD). Drug Discov Today, 2007,12:740-747.
8Dentin R, Girard J, Postic C. Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c) : two key regulators of glucose metabolism and lipid synthesis in liver. Biochimic, 2005, 87:81-86.
9Ferre P , Foufelle F. SREBP-Ic Transcription Factor and Lipid Homeostasis: Clinical Perspective. Horm Res, 2007, 68: 72-82.
10Ide T, Shimano H, Yahagi N, et al. SREBPs suppress IRS2 mediated insulin signaling in the liver. Nat Cell Biol,2004,6.-351-357.
5Singh MN, Martin-Hirsch PL, Martin FL. The multiple ap- plications of tamoxifen: an example pointing to SERM modulation being the aspirin of the 21st century[J]. Med Sci Monit,2008,14(9) :RA144.
6McGonigle KF, Smith DD, Marx HF, et al. Uterine effects of tamoxifen: a prospective study[J], lnt J Gynecol Can- cer,2006,16(2) :814.
7Akhondi-Meybodi M, Mortazavy-Zadah MR, Hashemian Z, et al. Incidence and risk factors for non-alcoholic ste- atohepatitis in females treated with tamoxifen for breast cancer[J]. Arab J Gastroenterol, 2011,12( 1 ) : 34.
8Joshi-Barve S, Barve SS, Amancherla K, et al. Palmitic ac- id induces production of proinflammatory cytokine inter- leukin-8 from hepatocytes[J]. Hepatology, 2007, 46 (3) : 823.
9Viollet B, Guigas B, Leclerc J, et al. AMP-activated pro- tein kinase in the regulation of hepatic energy metabo- lism: from physiology to therapeutic perspectives[J]. Acta Physiol: Oxf ,2009,196(1) :81.
10Edwards P A,Tabor D,Kast H R. Regulation of gene expression by SREBP and SCAP[J].{H}Biochimica et Biophysica Acta,2000.103-113.
